Related references
Note: Only part of the references are listed.Current FDA-Approved Therapies for High-Grade Malignant Gliomas
Jacob P. Fisher et al.
BIOMEDICINES (2021)
Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma
Wei Wu et al.
TRANSLATIONAL ONCOLOGY (2020)
Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
Christine M. Heske
FRONTIERS IN ONCOLOGY (2020)
A steroidal saponin form Paris vietnamensis (Takht.) reverses temozolomide resistance in glioblastoma cells via inducing apoptosis through ROS/PI3K/Akt pathway
Shan Zhang et al.
BIOSCIENCE TRENDS (2020)
Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment
Belen Delgado-Martin et al.
ADVANCED SCIENCE (2020)
Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas
Anqi Yao et al.
MOLECULAR NEUROBIOLOGY (2020)
Glutaminases regulate glutathione and oxidative stress in cancer
Jose M. Mates et al.
ARCHIVES OF TOXICOLOGY (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling
Jinyun Liu et al.
MOLECULAR THERAPY (2020)
Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres
Deborah Fanfone et al.
CANCERS (2020)
Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy
Mirna Jovanovic et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries
Clarissa Ribeiro Reily Rocha et al.
CELLS (2020)
Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells
Hye-Kyung Park et al.
CANCER RESEARCH (2019)
The role of thioredoxin system in cancer: strategy for cancer therapy
Jin-Jing Jia et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells
Zhengxin Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Antioxidant Defenses: A Context-Specific Vulnerability of Cancer Cells
Jordan A. Cockfield et al.
CANCERS (2019)
Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy
Mirna Jovanovic et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity, and Sensitizes Glioma Cells to Temozolomide
Dejiang Pang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chia-Hung Chien et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis
Zhongling Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal et al.
JOURNAL OF CELL BIOLOGY (2018)
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
Zhenyi An et al.
ONCOGENE (2018)
THE KEAP1-NRF2 SYSTEM: A THIOL-BASED SENSOR-EFFECTOR APPARATUS FOR MAINTAINING REDOX HOMEOSTASIS
Masayuki Yamamoto et al.
PHYSIOLOGICAL REVIEWS (2018)
Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
Nerino Allocati et al.
ONCOGENESIS (2018)
8-Oxoguanine DNA glycosylase 1: Beyond repair of the oxidatively modified base lesions
Xueqing Ba et al.
REDOX BIOLOGY (2018)
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma
Samuel K. McBrayer et al.
CELL (2018)
Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells
Bodo Haas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The role of cellular reactive oxygen species in cancer chemotherapy
Haotian Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Drug repurposing for the treatment of glioblastoma multiforme
Claudia Abbruzzese et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance
Lisa Y. Pang et al.
ONCOTARGET (2017)
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase
Kwang-Yu Chang et al.
REDOX BIOLOGY (2017)
Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells
Ulf D. Kahlert et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids
Eduard H. Panosyan et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells
Raffaela Silvestre Ignarro et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance
Monika D. Polewski et al.
MOLECULAR CANCER RESEARCH (2016)
ROS homeostasis and metabolism: a dangerous liason in cancer cells
E. Panieri et al.
CELL DEATH & DISEASE (2016)
Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema
Tina Sehm et al.
ONCOTARGET (2016)
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Clarissa Ribeiro Reily Rocha et al.
ONCOTARGET (2016)
Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway
Jun Feng et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Physiological and pathophysiological roles of NAMPT and NAD metabolism
Antje Garten et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion
L. Sleire et al.
ONCOGENE (2015)
Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function
Liangyu Chen et al.
ONCOLOGY REPORTS (2015)
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
Deepak Sampath et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Carolina Vizcaino et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells
Yusuke S. Hori et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
Myrna R. Rosenfeld et al.
AUTOPHAGY (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
ROS Function in Redox Signaling and Oxidative Stress
Michael Schieber et al.
CURRENT BIOLOGY (2014)
Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation
Patrick T. Grogan et al.
INVESTIGATIONAL NEW DRUGS (2014)
Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells
Zi-Xiang Cong et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Detoxification of Oxidative Stress in Glioma Stem Cells: Mechanism, Clinical Relevance, and Therapeutic Development
Sung-Hak Kim et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma
Satoru Takeuchi et al.
NEUROLOGY INDIA (2014)
Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy
Encouse B. Golden et al.
NEUROSURGICAL FOCUS (2014)
Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling
Haitao Yin et al.
ONCOLOGY REPORTS (2014)
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
Antonio Ayala et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
John D. Hayes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
In situ electrochemical evaluation of anticancer drug temozolomide and its metabolites-DNA interaction
Ilanna C. Lopes et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Nrf2 is required to maintain the self-renewal of glioma stem cells
Jianhong Zhu et al.
BMC CANCER (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
J.M. Mates et al.
CURRENT MOLECULAR MEDICINE (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Increased xCT Expression Correlates With Tumor Invasion and Outcome in Patients With Glioblastomas
Satoru Takeuchi et al.
NEUROSURGERY (2013)
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
Ping Mao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
Abena S. Agyeman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Yoichiro Mitsuishi et al.
CANCER CELL (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Resveratrol Enhances the Antitumor Effects of Temozolomide in Glioblastoma via ROS-dependent AMPK-TSC-mTOR Signaling Pathway
Yuan Yuan et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Sulfasalazine for brain cancer fits
Harald Sontheimer et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Aldehyde dehydrogenases and cell proliferation
G. Muzio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Alkylation Sensitivity Screens Reveal a Conserved Cross-species Functionome
David Svilar et al.
MOLECULAR CANCER RESEARCH (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Aldehyde dehydrogenase 1A1-a new mediator of resistance to temozolomide in glioblastoma
Andrea Schaefer et al.
NEURO-ONCOLOGY (2012)
Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities
Edith Lubos et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production
Claudia R. Oliva et al.
PLOS ONE (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
Meghan J. Seltzer et al.
CANCER RESEARCH (2010)
Reactive oxygen species in cancer
Geou-Yarh Liou et al.
FREE RADICAL RESEARCH (2010)
Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition
Wen-bin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
Claudia R. Oliva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
Michael Rasper et al.
NEURO-ONCOLOGY (2010)
Intratumoral patterns of clonal evolution in gliomas
Ana Luisa Vital et al.
NEUROGENETICS (2010)
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
Pierre A. Robe et al.
BMC CANCER (2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Sumihito Nobusawa et al.
CLINICAL CANCER RESEARCH (2009)
Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-κB
W. Joon Chung et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intracellular redox status and oxidative stress:: implications for cell proliferation, apoptosis, and carcinogenesis
Jose M. Mates et al.
ARCHIVES OF TOXICOLOGY (2008)
Mechanisms of chemoresistance to alkylating agents in malignant glioma
Jann N. Sarkaria et al.
CLINICAL CANCER RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis
Hae Kyung Lee et al.
NEURO-ONCOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress
Rintaro Okoshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Autocrine glutamate signaling promotes glioma cell invasion
Susan A. Lyons et al.
CANCER RESEARCH (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
The signaling mechanism of ROS in tumor progression
Wen-Sheng Wu
CANCER AND METASTASIS REVIEWS (2006)
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities
Elizabeth A. Maher et al.
CANCER RESEARCH (2006)
Inhibition of cystine uptake disrupts the growth of primary brain tumors
WJ Chung et al.
JOURNAL OF NEUROSCIENCE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
ROS stress in cancer cells and therapeutic implications
H Pelicano et al.
DRUG RESISTANCE UPDATES (2004)
The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase
SB Cullinan et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A distinct side population of cells with high drug efflux capacity in human tumor cells
C Hirschmann-Jax et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients
S Ostermann et al.
CLINICAL CANCER RESEARCH (2004)
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells
S Dolma et al.
CANCER CELL (2003)
Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates
M Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression
H Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice
SA Chanas et al.
BIOCHEMICAL JOURNAL (2002)
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc- cystine transporter:: a new action for an old drug
PW Gout et al.
LEUKEMIA (2001)
Glutamate release promotes growth of malignant gliomas
T Takano et al.
NATURE MEDICINE (2001)
Metabolism and functions of glutathione in brain
R Dringen
PROGRESS IN NEUROBIOLOGY (2000)
Physiological functions of thioredoxin and thioredoxin reductase
ESJ Arnér et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
